Dermata Therapeutics Inc - ESG Rating & Company Profile powered by AI
Detailed ESG assessment of Dermata Therapeutics Inc can be accessed by signing up for free. The assessment of Dermata Therapeutics Inc incorporates data from across the internet as well as from available filings by Dermata Therapeutics Inc. The ESG score covers 17 UN Sustainable Development Goals including: 'Affordable & Clean Energy', 'Industry, Innovation & Infrastructure' and 'Life on Land'.
Dermata Therapeutics Inc in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Dermata Therapeutics Inc | 8.0 | High |
| 1 | Analytik Jena AG | 8.0 | High |
| 1 | Amniotics AB (publ) | 8.0 | High |
| ... | ... | ... | |
| 182 | Wesana Health Holdings Inc | 0.0 | Low |
| 182 | rEVO Biologics Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Dermata Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Dermata Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Dermata Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Dermata Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Dermata Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Dermata Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Dermata Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Dermata Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Dermata Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Dermata Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Dermata Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Dermata Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Dermata Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Dermata Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Dermata Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Dermata Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Dermata Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Dermata Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of hyperhidrosis and aesthetic conditions. The company was incorporated in 2014 and is headquartered in San Diego, California.